Oxford, United Kingdom

James Miskin


 

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2008-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of James Miskin

Introduction

James Miskin is a notable inventor based in Oxford, GB, recognized for his significant contributions to the field of viral vector technology. With a total of four patents to his name, Miskin has made strides in the development of processes that enhance the efficiency of viral vector formulations.

Latest Patents

Miskin's latest patents include a process for virus purification, which involves producing a retroviral or lentiviral vector formulation that incorporates a filter-sterilization step that is not the final step in the purification process. Another significant patent is related to a multicistronic retroviral vector genome, which features a first nucleic acid sequence positioned upstream of at least one internal regulatory element. This innovation increases the level of genomic RNA available for packaging in the absence of rev or a functional equivalent.

Career Highlights

Throughout his career, Miskin has worked with prominent companies in the biotechnology sector, including Oxford Biomedica Limited and Oxford Biomedica, Inc. His work has been instrumental in advancing the capabilities of viral vectors, which are crucial for gene therapy and other medical applications.

Collaborations

Miskin has collaborated with notable professionals in his field, including Kyriacos Andreou Mitrophanous and Richard Truran. These collaborations have further enriched his research and development efforts.

Conclusion

James Miskin's innovative work in viral vector technology and his contributions to the biotechnology industry underscore his importance as an inventor. His patents reflect a commitment to advancing scientific knowledge and improving therapeutic techniques.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…